Medtronic plc Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD from Q1 2014 to Q4 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary: Medtronic plc quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and growth rate from Q1 2014 to Q4 2024.
Medtronic plc Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending January 24, 2025 was $49.6B, a 4.58% decline year-over-year.

Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)

Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2024	$49.6B	-$2.38B	-4.58%	Jan 24, 2025	10-Q	2025-02-25
Q3 2024	$48.7B	-$2.93B	-5.68%	Oct 25, 2024	10-Q	2025-02-25
Q2 2024	$48.2B	-$3.21B	-6.24%	Jul 26, 2024	10-Q	2025-02-25
Q1 2024	$50.4B	-$1.25B	-2.41%	Apr 26, 2024	10-Q	2025-02-25
Q4 2023	$52B	+$378M	+0.73%	Jan 26, 2024	10-Q	2025-02-25
Q3 2023	$51.6B	-$410M	-0.79%	Oct 27, 2023	10-Q	2025-02-25
Q2 2023	$51.4B	-$1.48B	-2.8%	Jul 28, 2023	10-Q	2025-02-25
Q1 2023	$51.7B	-$1.06B	-2.01%	Apr 28, 2023	10-Q	2025-02-25
Q4 2022	$51.6B	-$1.1B	-2.08%	Jan 27, 2023	10-Q	2024-02-27
Q3 2022	$52.1B	-$102M	-0.2%	Oct 28, 2022	10-Q	2024-02-27
Q2 2022	$52.8B	+$1.18B	+2.28%	Jul 29, 2022	10-Q	2024-02-27
Q1 2022	$52.7B	+$1.12B	+2.17%	Apr 29, 2022	10-K	2024-06-20
Q4 2021	$52.7B	+$1.79B	+3.51%	Jan 28, 2022	10-Q	2023-03-01
Q3 2021	$52.2B	+$1.84B	+3.66%	Oct 29, 2021	10-Q	2023-03-01
Q2 2021	$51.7B	+$1.22B	+2.42%	Jul 30, 2021	10-Q	2023-03-01
Q1 2021	$51.6B	+$730M	+1.44%	Apr 30, 2021	10-K	2024-06-20
Q4 2020	$50.9B	-$1.03B	-1.97%	Jan 29, 2021	10-Q	2022-03-03
Q3 2020	$50.3B	-$403M	-0.8%	Oct 30, 2020	10-Q	2022-03-03
Q2 2020	$50.4B	-$54M	-0.11%	Jul 31, 2020	10-Q	2022-03-03
Q1 2020	$50.9B	+$660M	+1.31%	Apr 24, 2020	10-K	2023-06-22
Q4 2019	$52B	+$2.01B	+4.03%	Jan 24, 2020	10-Q	2021-03-05
Q3 2019	$50.7B	+$1.01B	+2.02%	Oct 25, 2019	10-Q	2021-03-05
Q2 2019	$50.5B	+$168M	+0.33%	Jul 26, 2019	10-Q	2021-03-05
Q1 2019	$50.2B	-$610M	-1.2%	Apr 26, 2019	10-K	2022-06-23
Q4 2018	$49.9B	-$399M	-0.79%	Jan 25, 2019	10-Q	2020-02-28
Q3 2018	$49.7B	-$1.86B	-3.61%	Oct 26, 2018	10-Q	2020-02-28
Q2 2018	$50.3B	-$458M	-0.9%	Jul 27, 2018	10-Q	2020-02-28
Q1 2018	$50.8B	+$492M	+0.98%	Apr 27, 2018	10-K	2021-06-25
Q4 2017	$50.3B	+$847M	+1.71%	Jan 26, 2018	10-Q	2019-03-01
Q3 2017	$51.6B	+$1.29B	+2.56%	Oct 27, 2017	10-Q	2018-11-29
Q2 2017	$50.8B	-$105M	-0.21%	Jul 28, 2017	10-Q	2018-08-31
Q1 2017	$50.3B	-$1.65B	-3.17%	Apr 28, 2017	10-K	2020-06-19
Q4 2016	$49.5B			Jan 27, 2017	10-Q	2018-03-02
Q3 2016	$50.3B			Oct 28, 2016	10-Q	2017-12-04
Q2 2016	$50.9B			Jul 29, 2016	10-Q	2016-09-07
Q1 2016	$52B	-$1.17B	-2.2%	Apr 29, 2016	10-K	2019-06-21
Q1 2015	$53.1B	+$33.7B	+173%	Apr 24, 2015	10-K	2018-06-22
Q1 2014	$19.4B			Apr 25, 2014	10-K	2017-06-27

Previous1Next

Showing 1 to 38 of 38 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.